LIFR and cancer: Several tumors exhibit upregulated JAK/STAT, ERK/MAPK, and PI3K/AKT signaling via autocrine or paracrine activation of LIF/LIFR GP130, and this pathway significantly contributes to EMT in several cancers, disease progression, and a poorer relapse-free survival in several cancers (51).